Arkansas e-tracking PSE
This article was originally published in The Tan Sheet
Executive Summary
Sales of OTC products containing pseudoephedrine across Arkansas are being tracked on a real-time statewide electronic logbook, state Attorney General Dustin McDaniel says June 4. Arkansas was among the states that imposed behind-the-counter sales of PSE-containing OTC products before the federal Combat Methamphetamine Epidemic Act of 2006 required all states to implement sales restrictions as least as stringent (1"The Tan Sheet" July 3, 2006, p. 7). However, Arkansas found paper logbooks ineffective against meth makers who stock up on PSE drugs by visiting multiple retailers. Federal legislation, S. 1276, to fund electronic logs for states has stalled in the Senate, but Arkansas and other states - including Iowa, Oklahoma and Tennessee - have implemented their own tracking systems (2"The Tan Sheet" March 19, 2007, p. 11)...
You may also be interested in...
Meth ruling goes to pharma
Twenty Arkansas counties failed to show pharmaceutical firms were responsible for the "societal effects of the methamphetamine epidemic," according to the Jan. 5 decision by the U.S. Court of Appeals for the Eighth Circuit to dismiss the counties' complaint. The counties alleged that the companies opposed regulatory efforts in order to reap profits from the sale of OTC cough/cold products with ephedrine or pseudoephedrine. Arkansas, which ordered behind-the-counter sales of PSE-containing products before the federal Combat Meth Act of 2006 was enacted, instituted e-tracking for PSE product sales in 2008 (1"The Tan Sheet" June 9, 2008, In Brief)
State Pseudoephedrine Proposals Go Above, Beyond Combat Meth Act
The National Association of Chain Drug Stores has "concerns" with state bills proposing the establishment of real-time electronic repositories to monitor and limit pseudoephedrine sales, according to the trade group
Retailers Anxiously Await DEA Guidelines On Meth Act, PSE Logbooks
Chain drug stores are growing increasingly worried about their ability to implement provisions of the Combat Meth Act before the Sept. 30 deadline as the Drug Enforcement Administration continues to delay issuing its new requirements for sale of pseudoephedrine products, according to NACDS VP-Pharmacy Regulatory Affairs Kevin Nicholson